Orla DTx provides digital therapeutics that include remote monitoring of International Normalized Ratio (INR) levels and diagnostic support for asthma management. This service enables patients to effectively manage anticoagulation therapy and respiratory health, thereby minimizing the risk of complications associated with these conditions.
Funding
Funding not disclosed
Founders
Product
Problem
Managing chronic conditions like anticoagulation therapy and asthma often requires frequent monitoring and can lead to complications if not properly managed. Traditional monitoring methods can be inconvenient for patients and may not provide timely insights for healthcare professionals.
Solution
Orla DTx develops digital therapeutics that facilitate remote monitoring of International Normalized Ratio (INR) levels for patients on anticoagulation therapy and Peak Expiratory Flow (PEF) for asthma management. Their platform enables patients to monitor their condition from home, providing healthcare professionals with timely data to adjust treatment plans and minimize the risk of complications. By partnering with pharmaceutical, diagnostic, and MedTech companies, Orla DTx aims to integrate its solutions into existing healthcare workflows, enhancing patient self-care and improving overall disease management. The company's focus is on providing impactful services that contribute to sustainable healthcare by addressing the challenges in primary healthcare.
Target Audience
The primary target audience includes healthcare professionals (HCPs) managing patients on anticoagulation therapy or with asthma, as well as pharmaceutical, diagnostic, and MedTech companies seeking to integrate digital therapeutics into their offerings.
Features
- Remote monitoring of INR levels for anticoagulation therapy management
- Remote monitoring of PEF for asthma management
- Mobile application for patients to self-monitor and transmit data
- Integration with healthcare professionals' workflows for timely intervention
- Development of digital therapeutic solutions in partnership with Pharma, Diagnostics, and MedTech companies